Contents: Section 1: Herbal Products and
Regulations 1. Overview
on Herbal Product
Regulations: Challenges and Solution Section 2: Herbs and Derived
Products 2.
Extraction, Purification, Preliminary Phytochemical Screening and Structural Elucidation of Natural
Products 3. Herbal Formulations: Traditional, Conventional and NDDS 4. Herbal Cosmetics and Regulations 5. Nutraceuticals and Regulations 6. Labeling
and Packaging of Herbal Products Section 3: Traditional Medicines
Regulations 7. Indian Systems of Medicines, Regulations and Related Guidelines 8. WHO - General
Guidelines for Methodologies on Research and Evaluation of Traditional Medicine 2000 9. Drug & Cosmetic Act, 1940-Schedule T Good Manufacturing
Practice of Indian Systems of Medicine Section 4: Quality Control, Standardisation, Regulations for Herbal
Products 10. WHO Good
Agricultural and Collection Practices [GAP, GCP, GACP] 2003 11. NMPB Guidelines
and Standard for Good Field Collection Practices for Medicinal Plants 2009 12. WHO Guidelines on Good Herbal Processing Practice
for Herbal Medicine 2018 13. WHO Guidelines on Good Storage and Distribution Practices 2019 14. Herbal
Monograph, Pharmacopoeias, Markers 15. WHO Guidelines for Selecting Marker Substances of Herbal Origin for Quality Control of Herbal
Medicines 2017 16. WHO and
ICH Guidelines for Quality Control of Herbal Materials 17. Stability
Testing and Shelf Life Determination of Herbal Medicines
Section 5: Pre-clinical and
Toxicity Regulations for Herbal Products 18. CPCSEA and
OECD Guidelines for Animal
Experimentation 19. Human Dose Calculation Guidelines 20. WHO Guidelines for Assessment, Evaluation of
Toxicity, Safety and Efficacy of Herbal Medicines 2000 21. AYUSH General
Guidelines for Safety/Toxicity Evaluation of Ayurvedic Formulations 2018 Section 6: Pharmacovigilance and Clinical
Trial Regulations for Herbal Products 22. WHO Guidelines
on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems 2004 23. Fundamentals of Clinical Trails and Phases of
Trials 24. AYUSH Guidelines of Good Clinical
Practices 2018 25. CDSCO Guidelines of Good Clinical
Practices 2013 26. Ethical Principles for Clinical Trials 27. ICH Guidelines for Good Clinical Practices 2016 Section 7: Herbal Industry, IPR and
Regulatory Affairs 28. Herbal Industry: Infrastructure,
Formulation, Production and Pilot Plant
Scale-Up Management of Herbal Products 29. Herbal Entrepreneurship 30. Herbal Raw Material Trade 31. GMP, GLP, TQM
and ISO for Herbal Medicines 32. Intellectual
Property Rights and Herbal Products 33. Geographical
Indications of Goods (Registration and Protection) Act, 1999 34. New Drug Application: NDA, INDA, ANDA, BLA, OTC 35. Master Formula, SMF-Site Master
File, DMF-Drug Master File,
Dossier and CTD, Chemistry Manufacturing & Controls (CMC) Dossier |